methylene blue has been researched along with Systemic Inflammatory Response Syndrome in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bräuer, A; Busch, T; Friedrich, M; Lotfi, S; Mielck, F; Tirilomis, T | 1 |
Dagenais, F; Mathieu, P | 1 |
Boullon, FJ; Bruno, GF; Degrange, MA; Del Mazo, CD; Griotti, JJ; Levin, RL; Taborda, DJ | 1 |
Gracias, VH; Grossman, MD; Sarani, B; Sims, C; Stawicki, SP | 1 |
1 review(s) available for methylene blue and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
Methylene blue and vasoplegia: who, when, and how?
Topics: Animals; Humans; Hypotension; Methylene Blue; Molecular Structure; Syndrome; Systemic Inflammatory Response Syndrome | 2008 |
1 trial(s) available for methylene blue and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
Topics: Cardiopulmonary Bypass; Cause of Death; Coronary Disease; Enzyme Inhibitors; Female; Heart Valve Diseases; Hemodynamics; Humans; Hypotension; Infusions, Intravenous; Male; Methylene Blue; Middle Aged; Nitric Oxide; Postoperative Complications; Risk Factors; Survival Rate; Systemic Inflammatory Response Syndrome; Vascular Resistance | 2004 |
2 other study(ies) available for methylene blue and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
Methylene blue administration in severe systemic inflammatory response syndrome (SIRS) after thoracic surgery.
Topics: Aged; Coronary Artery Bypass; Enzyme Inhibitors; Hemodynamics; Humans; Male; Methylene Blue; Norepinephrine; Postoperative Complications; Pulmonary Atelectasis; Systemic Inflammatory Response Syndrome; Vasoconstrictor Agents | 2002 |
Rescue therapy with methylene blue in systemic inflammatory response syndrome after cardiac surgery.
Topics: Aged; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Enzyme Inhibitors; Heart Diseases; Humans; Male; Methylene Blue; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2003 |